Table 4.
Association of expression level of FMNL2 with brain infarcts in all brain samples in the dorsolateral prefrontal cortex from ROSMAP
Infarcts | b | SE | p | pFDR |
---|---|---|---|---|
Gross chronic infarctions in cortex | 1.024 | 0.295 | 5.21 × 10–4 | 0.003 |
Gross subacute infarctions in cortex | 0.697 | 0.467 | 0.135 | 0.181 |
Micro subacute infarctions in cortex | 0.017 | 0.542 | 0.975 | 0.975 |
Chronic infarctions in cortex, regardless of size | 0.525 | 0.226 | 0.020 | 0.060 |
Subacute infarctions in cortex, regardless of size | 0.519 | 0.361 | 0.151 | 0.181 |
Infarctions in cortex, regardless of size/age | 0.388 | 0.206 | 0.060 | 0.120 |
b estimate, SE standard error, p p value, pFDR FDR adjusted p value. The expression of FMNL2 was increased in pathological AD with gross chronic infarcts compared to pathological AD without gross chronic infarcts (b = 0.792, p = 0.025)